Where I see patients (1)
My reviews
Selected research
-
CPX-351 plus gemtuzumab ozogamicin for relapsed/refractory acute myelogenous leukemia: a University of California Hematologic Malignancies Consortium trial.
Leukemia & lymphoma
-
Impact of prior inotuzumab ozogamicin treatment on brexucabtagene autoleucel outcomes in adults with B-cell ALL.
Blood advances
-
Obecabtagene Autoleucel in Adults with B-Cell Acute Lymphoblastic Leukemia.
The New England journal of medicine
Clinical trials
Ruxolitinib With De-Intensified HLH-94 for the Treatment of Hemophagocytic Lymphohistiocytosis ...
The proportion of responder (complete response (CR) or partial response (PR)) or non-responder at the end of induction using a physician developed response criteria will be reported. Those with non-malignant HLH (nmHLH) will be as...
Recruiting
Contact me
- Request appointment
- Refer a patient
- (415) 353-2421
4.9